Task: Answer the multiple choice question.
Query: Which drug exhibits a -4.234% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC1(C)Cc2c(C#N)c(NCCO)nc(-c3ccco3)c2CO1
b COC(=O)c1cc(C#N)c(Oc2ccc(OC)cc2)nc1C
c CC(C)=CCN1CCN(Cc2cc(C(C)C)n[nH]2)CC1CCO
Answer: a. CC1(C)Cc2c(C#N)c(NCCO)nc(-c3ccco3)c2CO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)Cc2c(C#N)c(NCCO)nc(-c3ccco3)c2CO1
CC1(C)Cc2c(C#N)c(NCCO)nc(-c3ccco3)c2CO1
8-(furan-2-yl)-6-(2-hydroxyethylamino)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile